# SLAIN1

## Overview
SLAIN1 is a gene that encodes the protein SLAIN motif family member 1, which is integral to the regulation of microtubule dynamics within cells. This protein functions as a microtubule plus-end tracking protein, playing a pivotal role in cellular processes such as cell division and intracellular transport. SLAIN motif family member 1 interacts with end-binding (EB) proteins to facilitate the recruitment of the microtubule polymerase ch-TOG, thereby promoting microtubule polymerization and stability (Ravanidis2021Differentially; van2012Microtubule). Predominantly expressed in the developing nervous system, the protein is crucial for axon elongation and neuronal development, with disruptions in its function linked to neurodevelopmental disorders (Mir2019Advances; van2012Microtubule). Additionally, SLAIN1 has been implicated in cancer progression, particularly melanoma, and is involved in various cellular interactions that influence cytoskeletal organization and cell communication (Garrisi2014Proteomic; Lemonidis2017Peptide).

## Function
SLAIN1 is a protein that plays a critical role in the regulation of microtubule dynamics, which are essential for various cellular processes, including cell division and intracellular transport. It functions as a microtubule plus-end tracking protein, interacting with end-binding (EB) family members to promote persistent microtubule growth. This interaction facilitates the recruitment of the microtubule polymerase ch-TOG to microtubule plus-ends, enhancing microtubule polymerization and stability (Ravanidis2021Differentially; van2012Microtubule).

SLAIN1 is predominantly expressed in the developing nervous system, where it is crucial for axon elongation and neuronal development. The SLAIN1 protein, in conjunction with ch-TOG, is highly expressed in the brain and is vital for axon outgrowth in developing neurons. Disruption of the SLAIN-ch-TOG complex can lead to increased microtubule catastrophe frequency and inhibited axon extension, underscoring its importance in maintaining proper microtubule dynamics for neuronal development (van2012Microtubule).

In healthy human cells, SLAIN1 is active in the cytoplasm, where it regulates microtubule growth and stability, contributing to the structural integrity and plasticity of neuronal cells (Mir2019Advances).

## Clinical Significance
Mutations and alterations in the SLAIN1 gene have been associated with several neurodevelopmental and neurodegenerative disorders. A loss-of-function mutation in SLAIN1 has been linked to autosomal recessive intellectual disability (ARID), highlighting its critical role in neuronal development and function (Mir2019Advances; Harripaul2017Mapping). SLAIN1 is also implicated in the pathology of Parkinson's disease, where it hosts the circular RNA hsa_circ_0000497, which is differentially expressed in patients compared to healthy controls. This suggests a potential involvement in the disease's pathology through its role in neuronal processes (Ravanidis2021Differentially).

In addition to its role in neurological conditions, SLAIN1 has been identified as a transcription factor involved in cancer progression, particularly in melanoma. It is modulated by BRAF-mediated ERK activity, which is significant in the epithelial-mesenchymal transition, a process crucial for cancer metastasis (Garrisi2014Proteomic). Furthermore, SLAIN1 is a direct target of miR-454-3p, a microRNA downregulated in congenital pulmonary airway malformations, indicating its involvement in this condition as well (Zeng2021Analysis). These findings underscore the diverse clinical significance of SLAIN1 in both neurodevelopmental disorders and cancer.

## Interactions
SLAIN1 is involved in several key interactions that regulate microtubule dynamics. It interacts with the microtubule plus-end tracking proteins of the End Binding (EB) family, which are essential for targeting SLAIN1 to microtubule tips. This interaction is crucial for recruiting the microtubule polymerase ch-TOG to microtubule plus-ends, promoting persistent microtubule growth necessary for axon elongation in developing neurons (van2012Microtubule).

SLAIN1 also interacts with the zDHHC17 S-acyltransferase. Despite having non-favorable amino acids in their zDABM sequences, SLAIN1 can bind to the ankyrin-repeat domain of zDHHC17. This interaction was confirmed through co-immunoprecipitation assays, indicating that SLAIN1 forms complexes with zDHHC17, which may play a role in cellular processes such as cytoskeletal organization and cell communication (Lemonidis2017Peptide).

Additionally, SLAIN1 is targeted by miR-454-3p, a microRNA, as demonstrated by a dual-luciferase reporter assay. This interaction suggests a regulatory mechanism where miR-454-3p can influence SLAIN1 expression, impacting processes like congenital pulmonary airway malformations (Zeng2021Analysis).


## References


[1. (Mir2019Advances) Yaser Rafiq Mir and Raja Amir Hassan Kuchay. Advances in identification of genes involved in autosomal recessive intellectual disability: a brief review. Journal of Medical Genetics, 56(9):567–573, March 2019. URL: http://dx.doi.org/10.1136/jmedgenet-2018-105821, doi:10.1136/jmedgenet-2018-105821. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2018-105821)

[2. (Ravanidis2021Differentially) Stylianos Ravanidis, Anastasia Bougea, Dimitra Karampatsi, Nikolaos Papagiannakis, Matina Maniati, Leonidas Stefanis, and Epaminondas Doxakis. Differentially expressed circular <scp>rnas</scp> in peripheral blood mononuclear cells of patients with parkinson’s disease. Movement Disorders, 36(5):1170–1179, January 2021. URL: http://dx.doi.org/10.1002/mds.28467, doi:10.1002/mds.28467. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/mds.28467)

[3. (van2012Microtubule) Babet van der Vaart, Mariella A. M. Franker, Marijn Kuijpers, Shasha Hua, Benjamin P. Bouchet, Kai Jiang, Ilya Grigoriev, Casper C. Hoogenraad, and Anna Akhmanova. Microtubule plus-end tracking proteins slain1/2 and ch-tog promote axonal development. The Journal of Neuroscience, 32(42):14722–14728a, October 2012. URL: http://dx.doi.org/10.1523/jneurosci.1240-12.2012, doi:10.1523/jneurosci.1240-12.2012. This article has 41 citations.](https://doi.org/10.1523/jneurosci.1240-12.2012)

[4. (Zeng2021Analysis) Jiahang Zeng, Wei Liu, Jianhua Liang, Junzheng Peng, Fenghua Wang, Jue Tang, Qinglin Yang, Linwei Zhuang, Dongmei Huang, and Le Li. Analysis of mirna profiles and the regulatory network in congenital pulmonary airway malformations. Frontiers in Pediatrics, November 2021. URL: http://dx.doi.org/10.3389/fped.2021.671107, doi:10.3389/fped.2021.671107. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fped.2021.671107)

[5. (Lemonidis2017Peptide) Kimon Lemonidis, Ruth MacLeod, George S. Baillie, and Luke H. Chamberlain. Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zdhhc17 s-acyltransferase. Journal of Biological Chemistry, 292(42):17190–17202, October 2017. URL: http://dx.doi.org/10.1074/jbc.m117.799650, doi:10.1074/jbc.m117.799650. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m117.799650)

[6. (Harripaul2017Mapping) R Harripaul, N Vasli, A Mikhailov, M A Rafiq, K Mittal, C Windpassinger, T I Sheikh, A Noor, H Mahmood, S Downey, M Johnson, K Vleuten, L Bell, M Ilyas, F S Khan, V Khan, M Moradi, M Ayaz, F Naeem, A Heidari, I Ahmed, S Ghadami, Z Agha, S Zeinali, R Qamar, H Mozhdehipanah, P John, A Mir, M Ansar, L French, M Ayub, and J B Vincent. Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families. Molecular Psychiatry, 23(4):973–984, April 2017. URL: http://dx.doi.org/10.1038/mp.2017.60, doi:10.1038/mp.2017.60. This article has 136 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/mp.2017.60)

[7. (Garrisi2014Proteomic) Vito Michele Garrisi, Sabino Strippoli, Simona De Summa, Rosamaria Pinto, Antonella Perrone, Gabriella Guida, Amalia Azzariti, Michele Guida, and Tommasi Stefania. Proteomic profile and in silico analysis in metastatic melanoma with and without braf mutation. PLoS ONE, 9(12):e112025, December 2014. URL: http://dx.doi.org/10.1371/journal.pone.0112025, doi:10.1371/journal.pone.0112025. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0112025)